{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:34:26Z","timestamp":1768462466257,"version":"3.49.0"},"reference-count":45,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Tapered coronary artery lesions (TCALs) are often seen clinically, optimal stenting of TCALs remains challengeable. This study sought to compare clinical outcomes between the modified single stenting (MSS) and conventional overlapped stenting (COS) in treatment of TCALs. 150 patients were treated with MSS (MSS group), another 150 patients were matched with propensity score matching from 5055 patients treated with COS (COS group). Quantitative coronary angiography was performed to measure minimal lumen diameter (MLD), late lumen loss (LLL). The primary endpoint was immediate angiographic success, one-year cumulative major cardiac adverse events (MACEs) composing cardiac death, target vessel myocardial infarction (TVMI), target lesion\/vessel revascularization (TLR\/TVR) or stent thrombosis (ST). Post-procedural in-stent MLD (2.96 \u00b1 0.34 versus 3.08 \u00b1 0.33, P = 0.004) was smaller and diameter stenosis (11.7 \u00b1 4.0% versus 9.0 \u00b1 4.8%, P = 0.003) was higher in MSS group than COS group. At 1-year follow-up, in-stent MLD (2.76 \u00b1 0.38 mm versus 2.65 \u00b1 0.60 mm, P = 0.003) was reduced, LLL (0.20 \u00b1 0.26 mm versus 0.42 \u00b1 0.48 mm, P = 0.001), diameter stenosis (24.02 \u00b1 20.94% versus 19.68 \u00b1 11.75%, P = 0.028) and binary restenosis (18.7% versus 10.0%, P = 0.047) were increased in COS group. Angiographic success (96.7% versus 98.0%, P = 0.723) was similar between MSS group and COS group. At 1-year, the cumulative MACEs (12.0% versus 22.7%, P = 0.022) and TLR\/TVR (10.0% versus 18.7%, P = 0.047) were reduced in MSS group as compared to COS group, there was no difference in cardiac death, TVMI and ST between the groups. Compared to conventional overlapped stenting, modified single stenting for TCALs is associated with similar angiographic success, fewer one-year cumulative MACEs and less treatment cost.<\/jats:p>","DOI":"10.31083\/j.rcm2203101","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T02:35:45Z","timestamp":1632623745000},"source":"Crossref","is-referenced-by-count":5,"title":["Comparison of standard versus modified stenting technique for treatment of tapered coronary artery lesions"],"prefix":"10.31083","volume":"22","author":[{"given":"Dan","family":"Ke","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China"},{"name":"Fujian Institute of Coronary Artery Disease, 350001 Fuzhou, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"He","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China"},{"name":"Fujian Institute of Coronary Artery Disease, 350001 Fuzhou, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaogui","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China"},{"name":"Fujian Institute of Coronary Artery Disease, 350001 Fuzhou, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianglong","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fujian Medical University Union Hospital, 350001 Fuzhou, Fujian, China"},{"name":"Fujian Institute of Coronary Artery Disease, 350001 Fuzhou, Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"ref1","unstructured":"Roach MR, MacLean NF. The importance of taper proximal and distal to Y-bifurcations in arteries. Frontiers of Medical and Biological Engineering. 1993; 5: 127\u2013133."},{"key":"ref2","unstructured":"Zhang L, Xu D, Liu X, Wu X, Ying Y, Dong Z, et al. Coronary artery lumen diameter and bifurcation angle derived from CT coronary angiographic image in healthy people. Zhonghua Xin Xue Guan Bing Za Zhi. 2011; 39: 1117\u20131123. (In Chinese)"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Banka VS, Baker HA, Vemuri DN, Voci G, Maniet AR. Effectiveness of decremental diameter balloon catheters (tapered balloon). The American Journal of Cardiology. 1992; 69: 188\u2013193.","DOI":"10.1016\/0002-9149(92)91303-L"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Timmins LH, Meyer CA, Moreno MR, Moore JE. Mechanical modeling of stents deployed in tapered arteries. Annals of Biomedical Engineering. 2008; 36: 2042\u20132050.","DOI":"10.1007\/s10439-008-9582-0"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Banning AP, Lassen JF, Burzotta F, Lef\u00e8vre T, Darremont O, Hildick-Smith D, et al. Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European Bifurcation Club. EuroIntervention. 2019; 15: 90\u201398.","DOI":"10.4244\/EIJ-D-19-00144"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Foin N, Sen S, Allegria E, Petraco R, Nijjer S, Francis DP, et al. Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations? EuroIntervention. 2013; 8: 1315\u20131325.","DOI":"10.4244\/EIJV8I11A200"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Basalus M, van Houwelingen K, Ankone M, Feijen J, von Birgelen C. Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents. EuroIntervention. 2010; 6: 141\u2013148.","DOI":"10.4244\/EIJV6I1A21"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Gu\u00e9rin P, Pilet P, Finet G, Gou\u00ebffic Y, N\u2019Guyen JM, Crochet D, et al. Drug-eluting stents in bifurcations: bench study of strut deformation and coating lesions. Circulation: Cardiovascular Interventions. 2010; 3: 120\u2013126.","DOI":"10.1161\/CIRCINTERVENTIONS.108.846089"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"He R, Zhao L, Silberschmidt VV, Liu Y. Mechanistic evaluation of long-term in-stent restenosis based on models of tissue damage and growth. Biomechanics and Modeling in Mechanobiology. 2020; 19: 1425\u20131446.","DOI":"10.1007\/s10237-019-01279-2"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"He R, Zhao LG, Silberschmidt VV, Liu Y, Vogt F. Finite element evaluation of artery damage in deployment of polymeric stent with pre- and post-dilation. Biomechanics and Modeling in Mechanobiology. 2020; 19: 47\u201360.","DOI":"10.1007\/s10237-019-01194-6"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, et al. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 2006; 67: 595\u2013599.","DOI":"10.1002\/ccd.20665"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Honda Y, Muramatsu T, Ito Y, Sakai T, Hirano K, Yamawaki M, et al. Impact of ultra-long second-generation drug-eluting stent implantation. Catheterization and Cardiovascular Interventions. 2016; 87: E44\u2013E53.","DOI":"10.1002\/ccd.26010"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Kitabata H, Loh JP, Pendyala LK, Badr S, Dvir D, Barbash IM, et al. Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents. The American Journal of Cardiology. 2013; 112: 1093\u20131098.","DOI":"10.1016\/j.amjcard.2013.05.054"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Claessen BE, Smits PC, Kereiakes DJ, Parise H, Fahy M, Kedhi E, et al. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials. JACC: Cardiovascular Interventions. 2011; 4: 1209\u20131215.","DOI":"10.1016\/j.jcin.2011.07.016"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Naidu SS, Krucoff MW, Rutledge DR, Mao VW, Zhao W, Zheng Q, et al. Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study. JACC: Cardiovascular Interventions. 2012; 5: 626\u2013635.","DOI":"10.1016\/j.jcin.2012.02.014"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, R\u00e4ber L, et al. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). JACC: Cardiovascular Interventions. 2014; 7: 1093\u20131102.","DOI":"10.1016\/j.jcin.2014.04.017"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Ullrich H, M\u00fcnzel T, Gori T. Coronary Stent Thrombosis- Predictors and Prevention. Deutsches \u00c4rzteblatt International. 2020; 117: 320\u2013326.","DOI":"10.3238\/arztebl.2020.0320"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Jain RK, Chakravarthi P, Shetty R, Ramchandra P, Polavarapu RS, Wander GS, et al. One-year outcomes of a BioMimeTM Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: the meriT-3 study. Indian Heart Journal. 2016; 68: 599\u2013603.","DOI":"10.1016\/j.ihj.2016.09.007"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Podolec J, Niewiara \u0141, Baran J, Pieni\u0105\u017cek P, \u017bmudka K. First in Poland, unique 60-mm long single drug eluting tapered stent implantation in a patient with unstable angina. Kardiologia Polska. 2017; 75: 78.","DOI":"10.5603\/KP.2017.0003"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Valero E, Consuegra-S\u00e1nchez L, Mi\u00f1ana G, Garc\u00eda-Blas S, Rodr\u00edguez J, Moyano P, et al. Initial experience with the novel BioMimeTM 60 mm-long sirolimus-eluting tapered stent system in long coronary lesions. EuroIntervention. 2018; 13: 1591\u20131594.","DOI":"10.4244\/EIJ-D-17-00616"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zivelonghi C, van Kuijk JP, Nijenhuis V, Poletti E, Suttorp MJ, van der Heyden JAS, et al. First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm. Catheterization and Cardiovascular Interventions. 2018; 92: E299\u2013E307.","DOI":"10.1002\/ccd.27539"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Patted SV, Jain RK, Jiwani PA, Suryavanshi S, Raghu TR, Raveesh H, et al. Clinical Outcomes of Novel Long-Tapered Sirolimus-Eluting Coronary Stent System in Real-World Patients with Long Diffused De Novo Coronary Lesions. Cardiology Research. 2018; 9: 350\u2013357.","DOI":"10.14740\/cr795"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Podolec J, Skubera M, Niewiara \u0141, Podolec M, Pieni\u0105\u017cek P, Bartu\u015b K, et al. Clinical experience with 12-month follow-up in patients after implantation of a novel long-tapered sirolimus drug-eluting stent. Post\u0119py w Kardiologii Interwencyjnej. 2019; 15: 46\u201351.","DOI":"10.5114\/aic.2019.83648"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC)\/American College of Cardiology (ACC)\/American Heart Association (AHA)\/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction. Circulation. 2018; 138: e618\u2013e651.","DOI":"10.1161\/CIR.0000000000000617"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Mauri L, Hsieh W, Massaro JM, Ho KKL, D\u2019Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. The New England Journal of Medicine. 2007; 356: 1020\u20131029.","DOI":"10.1056\/NEJMoa067731"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Jurado-Rom\u00e1n A, Abell\u00e1n-Huerta J, Requena JA, S\u00e1nchez-P\u00e9rez I, L\u00f3pez-Lluva MT, Maseda-Uriza R, et al. Comparison of Clinical Outcomes Between Very Long Stents and Overlapping Stents for the Tretment of Diffuse Coronary Disease in Real Clinical Practice. Cardiovascular Revascularization Medicine. 2019; 20: 681\u2013686.","DOI":"10.1016\/j.carrev.2018.09.009"},{"key":"ref27","unstructured":"Park DW, Kim YH, Song HG, Ahn JM, Kim WJ, Lee JY, et al. Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial. JACC: Cardiovascular Interventions. 2011; 4: 1096\u20131103."},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Lee PH, Lee S, Yun S, Bae J, Ahn J, Park D, et al. Full Metal Jacket with Drug-Eluting Stents for Coronary Chronic Total Occlusion. JACC: Cardiovascular Interventions. 2017; 10: 1405\u20131412.","DOI":"10.1016\/j.jcin.2017.04.026"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Tan CK, Tin ZL, Arshad MKM, Loh JKK, Jafary FH, Ho HH, et al. Treatment with 48-mm everolimus-eluting stents: Procedural safety and 12-month patient outcome. Herz. 2019; 44: 419\u2013424.","DOI":"10.1007\/s00059-017-4670-2"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Yue X, Guo J, Zhang J, Cao C, Zhang Z, Shen D, et al. Evaluation of Mechanical Performances of Stents with 38\u2009mm Length in Long Lesion. BioMed Research International. 2020; 2020: 2594161.","DOI":"10.1155\/2020\/2594161"},{"key":"ref31","unstructured":"Haude M, Erbel R, Straub U, Dietz U, Schatz R, Meyer J. Coronary vessel stent implantation in patients with symptomatic dissections following balloon dilatation. Zeitschrift Fur Kardiologie. 1990; 79: 843\u2013849. (In German)"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Kastrati A, Elezi S, Dirschinger J, Hadamitzky M, Neumann FJ, Sch\u00f6mig A. Influence of lesion length on restenosis after coronary stent placement. The American Journal of Cardiology. 1999; 83: 1617\u20131622.","DOI":"10.1016\/S0002-9149(99)00165-4"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, et al. Stented segment length as an independent predictor of restenosis. Journal of the American College of Cardiology. 1999; 34: 651\u2013659.","DOI":"10.1016\/S0735-1097(99)00303-4"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Serruys PW, Foley DP, Suttorp MJ, Rensing BJWM, Suryapranata H, Materne P, et al. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. Journal of the American College of Cardiology. 2002; 39: 393\u2013399.","DOI":"10.1016\/S0735-1097(01)01760-0"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O\u2019Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. The New England Journal of Medicine. 2003; 349: 1315\u20131323.","DOI":"10.1056\/NEJMoa035071"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Schofer J, Schl\u00fcter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). The Lancet. 2003; 362: 1093\u20131099.","DOI":"10.1016\/S0140-6736(03)14462-5"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Aoki J, Ong AT, Rodriguez Granillo GA, McFadden EP, van Mieghem CA, Valgimigli M, et al. \u201cFull metal jacket\u201d (stented length > or = 64 mm) using drug-eluting stents for de novo coronary artery lesions. American Heart Journal. 2005; 150: 994\u2013999.","DOI":"10.1016\/j.ahj.2005.01.050"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, et al. Multiple Overlapping Drug-Eluting Stents to Treat Diffuse Disease of the Left Anterior Descending Coronary Artery. Journal of the American College of Cardiology. 2005; 45: 1570\u20131573.","DOI":"10.1016\/j.jacc.2005.01.049"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. The American Journal of Cardiology. 2004; 93: 826\u2013829.","DOI":"10.1016\/j.amjcard.2003.12.018"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Kereiakes DJ, Wang H, Popma JJ, Kuntz RE, Donohoe DJ, Schofer J, et al. Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. Journal of the American College of Cardiology. 2006; 48: 21\u201331.","DOI":"10.1016\/j.jacc.2006.02.058"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"R\u00e4ber L, J\u00fcni P, L\u00f6ffel L, Wandel S, Cook S, Wenaweser P, et al. Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. Journal of the American College of Cardiology. 2010; 55: 1178\u20131188.","DOI":"10.1016\/j.jacc.2009.11.052"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007; 27: 1500\u20131510.","DOI":"10.1161\/ATVBAHA.107.144220"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005; 112: 270\u2013278.","DOI":"10.1161\/CIRCULATIONAHA.104.508937"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Ng J, Foin N, Ang HY, Fam JM, Sen S, Nijjer S, et al. Over-expansion capacity and stent design model: an update with contemporary DES platforms. International Journal of Cardiology. 2016; 221: 171\u2013179.","DOI":"10.1016\/j.ijcard.2016.06.097"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Chen S. Rethinking overdilation of drug-eluting stents: an effective \u201cloose end\u201d. EuroIntervention. 2013; 8: 1235\u20131239.","DOI":"10.4244\/EIJV8I11A190"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/22\/3\/10.31083\/j.rcm2203101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T17:36:23Z","timestamp":1732728983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/22\/3\/10.31083\/j.rcm2203101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["1632453094339-287807902"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2203101","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"article-number":"931"}}